https www.wellsfargoadvisors.com dsip Experienced Investing - Diversified Stock Income Plan Blake Carmichael - Vice President

Linus Pauling Institute Oregon State University Updated in July 2018 by: Barbara Delage, Ph.D

I am not convinced the data is fully there yet. Tatem said he expects the hearings to be a hard-fought battle, but hopes committee members will consider what he described as real-world data from tens of millions of doses administered between 2014 and 2023

Subcutaneous dosing in research protocols is typically in the 1-2 mg range, though specific doses depend entirely on the study design and model

The 2007 peer-reviewed confirmation of GHK-Cu's direct hair growth promotion in human tissue, combined with the extensive evidence on follicle enlargement, anagen extension, and scalp angiogenesis, makes GHK-Cu one of the most biologically rational approaches to hair loss available in 2026

That being said, all studies were observational, meaning they cannot prove cause and effect